首页|期刊导航|中国临床药理学杂志|龙珠软膏治疗中度寻常型痤疮的随机、盲法、阳性药平行对照、多中心临床研究

龙珠软膏治疗中度寻常型痤疮的随机、盲法、阳性药平行对照、多中心临床研究OA

Clinical trial of Longzhu ointment on moderate acne vulgaris:A randomized,blinded,positive-drug parallel-controlled,multicenter study

中文摘要英文摘要

目的 探索龙珠软膏治疗中度寻常型痤疮的临床疗效和安全性.方法 将入组的中度寻常型痤疮患者根据治疗方法分为试验组和对照组.试验组外用龙珠软膏和过氧苯甲酰凝胶模拟剂,对照组外用过氧苯甲酰凝胶和龙珠软膏模拟剂,均为每天1次,晚上使用,疗程2周.记录基线、用药第8天、第15天的炎性皮损计数、非炎性皮损计数、研究者总体评估(IGA)评分的变化,进行组间比较并记录药物不良反应.结果 共筛选244例,试验组120例、对照组120例.试验组违背试验方案2例,自动退出1例,对照组违背试验方案2例,失访1例,不良事件脱落1例,最终试验组和对照组各纳入117例和116例.用药第8天,试验组和对照组的炎性皮损计数变化百分率分别为(22.00±30.00)%和(26.00±25.00)%,非炎性皮损计数变化百分率分别为(16.00±29.00)%和(22.00±28.00)%,IGA评分治疗成功率分别为24.79%(29例/117例)和29.31%(34例/116例),2组组间比较,在统计学上差异均无统计学意义(均P>0.05).用药第15天,试验组和对照组的炎性皮损计数变化百分率分别为(42.00±31.00)%和(48.00±27.00)%,非炎性皮损计数变化百分率分别为(34.00±32.00)%和(40.0±32.00)%,IGA 评分治疗成功率分别为 58.12%(68例/117例)和69.83%(81例/116例),2组组间比较,在统计学上差异均无统计学意义(均P>0.05).试验组药物不良反应有轻度刺痛、轻度瘙痒、烧灼感、干燥感,对照组药物不良反应有轻度刺痛、轻度瘙痒、干燥感、脱屑.试验组和对照组的药物不良反应总发生率分别为4.17%(5例/120例)和13.33%(16例/120例),在统计学上差异有统计学意义(P<0.05).结论 龙珠软膏治疗中度寻常型痤疮的临床疗效与对照药过氧苯甲酰凝胶疗效相当,且安全性更好.

Objective To investigate the efficacy and safety of Longzhu ointment in the treatment of moderate acne vulgaris.Methods Moderate acne vulgaris patients who met the inclusion criteria were divided into the treatment group and the control group according to the treatment regiment.The treatment group received topical Longzhu ointment plus benzoyl peroxide gel placebo,while the control group received topical benzoyl peroxide gel plus Longzhu ointment placebo.All medications were applied once daily at night for a 2-week treatment course.The changes in inflammatory lesion count,non-inflammatory lesion count,and Investigator's Global Assessment(IGA)score were recorded at baseline,day 8 of treatment,and day 15 of treatment.Intra-group and inter-group comparison was performed,and adverse drug reaction were documented throughout the study.Results A total of 244 patients were screened,with 120 patients allocated to the treatment group and 120 patients to the control group.In the treatment group,2 patients violated the trial protocol and 1 patient withdrew voluntarily;in the control group,2 patients violated the trial protocol,1 patient was lost to follow-up,and 1 patient dropped out due to adverse events.Finally,117 patients in the treatment group and 116 patients in the control group were included in the efficacy analysis.On day 8 of treatment,the percentage change in inflammatory lesion count was(22.00±30.00)%in the treatment group and(26.00±25.00)%in the control group;the percentage change in non-inflammatory lesion count was(16.00±29.00)%and(22.00±28.00)%,respectively;the IGA treatment success rate was 24.79%(29 cases/117 cases)and 29.31%(34 cases/116 cases),while intergroup comparisons showed no statistically significant differences between the two groups(all P>0.05).On day 15 of treatment,the percentage change in inflammatory lesion count was(42.00±31.00)in the treatment group and(48.00±27.00)in the control group;the percentage change in non-inflammatory lesion count was(34.00±32.00)%and(40.0±32.00)%,respectively;the IGA treatment success rate was 58.12%(68 cases/117 cases)and 69.83%(81 cases/116 cases)respectively,while intergroup comparisons showed no statistically significant differences between the two groups(all P>0.05).Adverse drug reactions in the treatment group included mild stinging,mild pruritus,burning sensation and dryness;those in the control group included mild stinging,mild pruritus,dryness and desquamation.The total incidence of adverse drug reactions was 4.17%(5 cases/120 cases)in the treatment group and 13.33%(16 cases/120 cases)in the control group,with a statistically significant difference between the two groups(P<0.05).Conclusion Longzhu ointment demonstrates comparable clinical efficacy to benzoyl peroxide gel in the treatment of moderate acne vulgaris,with a better safety profile.

张丰川;闫小宁;李文彬;邹雅欣;李琳琳;陈璐;贾敏;曾义燕;文昌晖;胡文韬;吴然;蔡玲玲;贺爱娟;叶建州;黄虹;张佩莲;杨瑾;王金容;胡桂兰;孔宇虹;孙占学;杨嫣然;聂晶;李悦;陈信生;莫秀梅

北京中医药大学东方医院皮肤科,北京 100078陕西省中医医院皮肤科,陕西西安 710003陕西省中医医院皮肤科,陕西西安 710003陕西省中医医院皮肤科,陕西西安 710003陕西省中医医院皮肤科,陕西西安 710003陕西省中医医院皮肤科,陕西西安 710003贵州中医药大学第一附属医院皮肤科,贵州贵阳 550001贵州中医药大学第一附属医院皮肤科,贵州贵阳 550001贵州中医药大学第一附属医院皮肤科,贵州贵阳 550001贵州中医药大学第一附属医院皮肤科,贵州贵阳 550001贵州中医药大学第一附属医院皮肤科,贵州贵阳 550001北京中医药大学东方医院皮肤科,北京 100078贵州中医药大学第一附属医院皮肤科,贵州贵阳 550001云南省中医医院皮肤科,云南 昆明 650032云南省中医医院皮肤科,云南 昆明 650032云南省中医医院皮肤科,云南 昆明 650032云南省中医医院皮肤科,云南 昆明 650032云南省中医医院皮肤科,云南 昆明 650032云南省中医医院皮肤科,云南 昆明 650032北京中医药大学东方医院皮肤科,北京 100078北京中医药大学第三附属医院皮肤科,北京 100191北京中医药大学第三附属医院皮肤科,北京 100191北京中医药大学第三附属医院皮肤科,北京 100191北京中医药大学第三附属医院皮肤科,北京 100191广东省中医皮肤病研究所,广东 广州 510120广东省中医皮肤病研究所,广东 广州 510120

医药卫生

龙珠软膏过氧苯甲酰凝胶寻常型痤疮炎性皮损计数

Longzhu ointmentbenzoyl peroxide gelacne vulgarisinflammatory lesion count

《中国临床药理学杂志》 2026 (14)

1992-1996,5

10.13699/j.cnki.1001-6821.2026.14.007

评论